What determines the sale of oral artemisinin monotherapy among private sector providers in Myanmar?

Download File


Myanmar Context & Rationale

  • More malaria than any other country in GMS (70% of total)
  • Commitment to eliminate malaria by 2030
  • Oral artemisinin monotherapy (AMT) was banned since 2012
  • Yet, sale and use of oral AMT is still common